Citius pharmaceuticals to participate in the 35th annual roth conference

Cranford, n.j. , march 8, 2023 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced its participation in the 35th annual roth conference being held march 12-14, 2023 in dana point, california.

CTXR Ratings Summary

CTXR Quant Ranking